Myanmar

3 Vaccines Approved for Use in Myanmar

Non Replicating Viral Vector

Gamaleya

Sputnik V

Approved in 74 countries
25 trials in 8 countries
Approval Source: reuters.com
Non Replicating Viral Vector

Serum Institute of India

Covishield (Oxford/ AstraZeneca formulation)

Approved in 49 countries
6 trials in 1 country
Approval Source: reuters.com
Inactivated

Sinopharm (Beijing)

Covilo

Approved in 93 countries
39 trials in 18 countries
Approval Source: global.chinadaily.com.cn